Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.

Turkolmez, KADİR; Beduk, Y; Baltaci, S; Gogus, ÇAĞATAY; Gogus, O

doi:10.1016/s0302-2838(03)00385-3

Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.

Turkolmez K., Beduk Y., Baltaci S., Gogus Ç. M., Gogus O.

European urology, vol.44, no.6, pp.682-6, 2003 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 44 Issue: 6
Publication Date: 2003
Doi Number: 10.1016/s0302-2838(03)00385-3
Journal Name: European urology
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.682-6
Keywords: gemcitabine, vinorelbine, bladder tumor, chemotherapy, TRANSITIONAL-CELL-CARCINOMA, PHASE-II TRIAL, METASTATIC UROTHELIAL CANCER, COOPERATIVE-ONCOLOGY-GROUP, URINARY-TRACT, BREAST-CANCER, METHOTREXATE, VINBLASTINE, COMBINATION, IFOSFAMIDE
Ankara University Affiliated: Yes

Abstract

Objective: To evaluate the efficacy and toxicity of gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are unsuitable for or who have failed cisplatin-containing chemotherapy.